Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure

Heart

Volumn 89, Issue 9, 2003, Pages 1085-1086

  Williams, S G ^a   Wright, D J ^a   Marshall, P ^a   Reese, A ^b   Tzeng, B H ^a   Coats, A J S ^c   Tan, L B ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ARROWE PARK HOSPITAL   (United Kingdom)

^c University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; NALOXONE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BREATHING RATE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; END TIDAL CARBON DIOXIDE TENSION; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HUMAN; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SIDE EFFECT; TIDAL VOLUME; TREATMENT OUTCOME;

EID: 0041326756     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.9.1085     Document Type: Article

References (5)

1. Rubin SA, Brown HV. Ventilation and gas exchange during exercise in severe chronic heart failure. Am Rev Respir Dis 1984;129(suppl S):S63-4.
2. Johnson MW, Mitch WE, Wilcox CS. The cardiovascular actions of morphine and the endogenous opioid peptides. Prog Cardiovasc Dis 1985;27:435-50.
3. Tan LB, Bryant S, Murray RG. Detrimental haemodynamic effects of cyclizine in patients with heart failure. Lancet 1988;i:560-1.
4. Cooke GA, Williams SG, Marshall P, et al. A mechanistic investigation of ACE inhibitor dose effects on aerobic exercise capacity in heart failure patients. Eur Heart J 2002;23:1360-8.
5. Chua TP, Harrington D, Ponikowski P, et al. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997;29:147-52.